A review published in JAMA found that bills introduced into the House and Senate don’t go nearly as far as existing drug-pricing regulations other countries. The researchers listed eight key lessons from six nations.

Source: http://feedproxy.google.com/~r/abovethelaw/~3/T4ZelmrCh4k/